Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis Ltd (DCAL) last reported results for the quarter ended Jun 2026, with sales of ₹678 crore and net profit of ₹-58 crore. The stock last traded at ₹154, a market capitalisation of ₹2,414 crore, on a P/E of 133. Over the past 52 weeks the stock has ranged between ₹128 and ₹307. Figures are as of 6 Oct 2026 and are not real time.
Dishman Carbogen Amcis Ltd share price and key metrics
- Current price
- ₹154
- Market cap
- ₹2,414 cr
- Stock P/E
- 133
- Book value
- ₹426
- ROE
- 1.58%
- ROCE
- 3.14%
- Dividend yield
- 0.00%
- 52w high / low
- 307/128
Metrics as of 6 Oct 2026. Not real time.
Track Dishman Carbogen Amcis Ltd
Cruxal reads every Dishman Carbogen Amcis Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Dishman Carbogen Amcis Ltd growth and returns
- 10 Years
- %
- 5 Years
- 9%
- 3 Years
- 7%
- TTM
- 0%
- 10 Years
- %
- 5 Years
- 21%
- 3 Years
- 140%
- TTM
- -85%
- 10 Years
- %
- 5 Years
- -9%
- 3 Years
- -2%
- 1 Year
- -47%
- 10 Years
- 1%
- 5 Years
- 0%
- 3 Years
- 0%
- Last Year
- 2%
Dishman Carbogen Amcis Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹678 cr, down 4.2% from ₹708 cr a year earlier. Net profit swung to a loss of ₹58 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 789 | 682 | 716 | 708 | 653 | 720 | 851 | 678 |
| Expenses | 642 | 542 | 564 | 567 | 504 | 607 | 688 | 618 |
| Operating profit | 147 | 140 | 153 | 141 | 149 | 113 | 163 | 60 |
| OPM % | 19% | 21% | 21% | 20% | 23% | 16% | 19% | 9% |
| Other income | 4 | 8 | -4 | 22 | 8 | 7 | 15 | 16 |
| Interest | 37 | 49 | 42 | 43 | 42 | 46 | 43 | 37 |
| Depreciation | 72 | 72 | 79 | 81 | 84 | 84 | 89 | 91 |
| Profit before tax | 42 | 27 | 28 | 39 | 31 | -10 | 46 | -51 |
| Tax % | 21% | 83% | -56% | 39% | -114% | 24% | 53% | 13% |
| Net profit | 33 | 5 | 43 | 23 | 65 | -13 | 22 | -58 |
| EPS (₹) | 2.11 | 0.30 | 2.75 | 1.49 | 4.16 | -0.83 | 1.39 | -3.69 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Dishman Carbogen Amcis Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,714 | 1,695 | 2,059 | 2,044 | 1,912 | 2,141 | 2,413 | 2,616 | 2,712 | 2,932 | 2,901 |
| Operating profit | 452 | 445 | 552 | 503 | 274 | 331 | 332 | 286 | 469 | 566 | 485 |
| OPM % | 26% | 26% | 27% | 25% | 14% | 15% | 14% | 11% | 17% | 19% | 17% |
| Net profit | 145 | 155 | 210 | 159 | -165 | 18 | -30 | -153 | 3 | 97 | 16 |
| EPS (₹) | — | 9.58 | 13.03 | 10.10 | -10.53 | 1.15 | -1.90 | -9.79 | 0.21 | 6.22 | 1.03 |
TTM is the trailing twelve months to the most recent quarter.
Dishman Carbogen Amcis Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 0.00 | 32 | 32 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 4,814 | 5,075 | 5,347 | 5,684 | 5,667 | 5,518 | 5,778 | 5,596 | 5,800 | 6,646 |
| Borrowings | 950 | 1,095 | 1,042 | 1,357 | 1,589 | 1,830 | 2,209 | 2,313 | 2,389 | 3,076 |
| Other liabilities | 811 | 967 | 899 | 1,121 | 1,068 | 1,255 | 1,421 | 1,631 | 1,766 | 2,158 |
| Total liabilities | 6,574 | 7,169 | 7,321 | 8,193 | 8,356 | 8,634 | 9,439 | 9,571 | 9,987 | 11,911 |
| Fixed assets | 4,852 | 5,066 | 5,098 | 5,678 | 5,698 | 5,773 | 6,188 | 6,724 | 7,055 | 8,076 |
| CWIP | 133 | 151 | 175 | 234 | 486 | 780 | 1,043 | 646 | 467 | 570 |
| Investments | 40 | 196 | 167 | 191 | 172 | 324 | 249 | 102 | 97 | 91 |
| Other assets | 1,550 | 1,757 | 1,881 | 2,091 | 2,000 | 1,758 | 1,959 | 2,098 | 2,368 | 3,174 |
| Total assets | 6,574 | 7,169 | 7,321 | 8,193 | 8,356 | 8,634 | 9,439 | 9,571 | 9,987 | 11,911 |
As reported by the company. Total assets equal total liabilities by construction.
Dishman Carbogen Amcis Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 303 | 226 | 282 | 585 | 513 | 355 | 266 | 379 | 371 | 491 |
| Cash from investing | -107 | -297 | -169 | -442 | -380 | -619 | -494 | -225 | -192 | -245 |
| Cash from financing | -137 | 78 | -102 | -98 | -11 | 130 | 250 | -22 | -102 | 201 |
| Net cash flow | 59 | 7 | 11 | 46 | 122 | -133 | 22 | 132 | 77 | 447 |
| Free cash flow | 164 | 22 | -26 | 177 | 147 | -101 | -352 | 76 | 156 | 225 |
| CFO / operating profit | 92% | 58% | 75% | 131% | 206% | 124% | 90% | 139% | 86% | 88% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Dishman Carbogen Amcis Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 5% | 6% | 4% | 0% | 1% | 1% | 0% | 2% | 3% |
| Debtor days | 61 | 96 | 79 | 103 | 80 | 81 | 89 | 68 | 90 | 84 |
| Inventory days | 473 | 525 | 496 | 462 | 402 | 526 | 568 | 540 | 655 | 910 |
| Days payable | 95 | 201 | 176 | 226 | 132 | 158 | 155 | 149 | 168 | 189 |
| Cash conversion cycle | 439 | 419 | 399 | 340 | 350 | 449 | 502 | 458 | 577 | 805 |
| Working capital days | 35 | 44 | 43 | -10 | -2 | -8 | -37 | -148 | -35 | -60 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Dishman Carbogen Amcis Ltd shareholding pattern
Promoters held 59.32% at Jun 2026, broadly unchanged since Jun 2025. FIIs 6.86% and DIIs 2.06%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% |
| FIIs | 8.18% | 8.75% | 9.49% | 9.94% | 8.07% | 7.66% | 7.45% | 6.86% |
| DIIs | 1.22% | 1.42% | 1.26% | 1.27% | 1.37% | 1.27% | 1.63% | 2.06% |
| Public | 31.29% | 30.51% | 29.94% | 29.48% | 31.23% | 31.75% | 31.60% | 31.76% |
| No. of shareholders | 55,280 | 52,822 | 50,757 | 49,744 | 49,455 | 48,481 | 49,009 | 49,430 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Dishman Carbogen Amcis Ltd corporate filings
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Company Updatelow impact
Cruxal's analysis: Please find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP)…
Read the full analysis - Dishman Carbogen Amcis Ltd. approves issuance of up to Rs. 38 crore senior, secured, rated, listed, and redeemable non-convertible debentures, along with security modifications for existing Rs. 15 crore NCDs, indicating strategic debt restructuring and expansion plans.Board Meetingmedium impact
Cruxal's analysis: Dishman Carbogen Amcis Ltd. has announced the approval of a private placement of up to…
Read the full analysis - Dishman Carbogen Amcis proposes to raise ₹15 crore via private placement of secured, rated, non-convertible debentures (NCDs) with a face value of ₹1 lakh each, allotted on September 28, 2026, and now seeking approval for modification/change in security.Board Meetingmedium impact
Cruxal's analysis: Dishman Carbogen Amcis Limited has announced a board meeting scheduled for October 7…
Read the full analysis - Dishman Carbogen Amcis Limited's AGM results reveal strong shareholder support for key resolutions, with over 99.99% voting in favor of financial and director re-appointment resolutions, indicating stable governance and investor confidence.AGM/EGMlow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited held its 19th AGM on 30th September 2026 via video…
Read the full analysis - Dishman Carbogen Amcis Limited holds AGM with no immediate financial disclosures; recent financials show volatile quarterly performance with net losses in several quarters but some recovery in late 2024 and 2025.AGM/EGMmedium impact
Cruxal's analysis: Dishman Carbogen Amcis Limited conducted its 19th AGM on 30th September 2026 via video…
Read the full analysis - Corporate Governance & Shareholder Approval Confirmed in Scrutinizer's Report for Dishman Carbogen Amcis Limited's 19th AGMAGM/EGMlow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited held its 19th AGM on 30th September 2026 via video…
Read the full analysis - Dishman Carbogen Amcis Ltd announces allotment of Non-Convertible Debentures (NCDs)Company Updatelow impact
Cruxal's analysis: Dishman Carbogen Amcis Ltd has formally intimated the allotment of Non-Convertible…
Read the full analysis - Pls. find enclosed herewith the intimation of closure of trading window for the quarter ending 30th September, 2026.Insider Trading / SASTlow impact
- Dishman Carbogen Amcis subsidiary completes US FDA inspection at Vionnaz site with zero observationsCompany Updatemedium impact
Cruxal's analysis: Dishman Carbogen Amcis Ltd announced that its wholly owned subsidiary, CARBOGEN AMCIS AG…
Read the full analysis - Dishman Carbogen Amcis Limited schedules 19th Annual General Meeting for 30th September 2026AGM/EGMlow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited has issued a formal notice for its 19th Annual General…
Read the full analysis - Dishman Carbogen Amcis Ltd files Business Responsibility and Sustainability Report (BRSR) for FY 2025-26Otherslow impact
Cruxal's analysis: Dishman Carbogen Amcis Ltd has submitted its Business Responsibility and Sustainability…
Read the full analysis - Dishman Carbogen Amcis Limited Announces 19th Annual General Meeting for FY 2025-26Otherslow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited has issued a notice for its 19th Annual General Meeting…
Read the full analysis - Dishman Carbogen Amcis Limited Announces 19th Annual General Meeting for September 30, 2026AGM/EGMlow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited has issued a formal notice for its 19th Annual General…
Read the full analysis - Dishman Carbogen Amcis Limited schedules 19th Annual General Meeting for 30th September 2026AGM/EGMlow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited has formally intimated the stock exchanges regarding the…
Read the full analysis - Dishman Carbogen Amcis Limited Announces Cessation of Vice President (Operation)Company Updatelow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited has formally notified the stock exchanges regarding the…
Read the full analysis - Dishman Carbogen Amcis Q1 FY27 Earnings Call: Revenue De-growth of 4% YoY Amidst Order Postponements and Strategic Debt Refinancing PlansCompany Updatehigh impact
Cruxal's analysis: Dishman Carbogen Amcis reported a soft Q1 FY27 with revenue of INR 677.6 crore, a 4% YoY…
Read the full analysis - Dishman Carbogen Amcis Limited releases audio recording of Q1 FY2026-27 earnings conference callCompany Updatelow impact
Cruxal's analysis: Dishman Carbogen Amcis Limited has filed the audio recording of its investor conference…
Read the full analysis - Dishman Carbogen Amcis Ltd announces allotment of Non-Convertible Debentures (NCDs)Company Updatelow impact
Cruxal's analysis: Dishman Carbogen Amcis Ltd has formally intimated the allotment of Non-Convertible…
Read the full analysis - Dishman Carbogen Amcis Reports Q1 FY27 Net Loss of 57.88 crore Amidst CDMO Revenue DefermentCompany Updatehigh impact
Cruxal's analysis: Dishman Carbogen Amcis Limited reported a weak Q1 FY27 performance with net revenue…
Read the full analysis - Dishman Carbogen Amcis reports Q1 FY27 consolidated net loss of 57.88 crore amid operational challengesResulthigh impact
Cruxal's analysis: Dishman Carbogen Amcis Limited reported a consolidated net loss of 57.88 crore for the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.